These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 29636182

  • 1. Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis.
    Isani M, Illingworth L, Herman E, Schmidt M, Barron L, Bowling J, Elizee M, Bai I, Gayer C, Grishin A, Erwin CR, Ford HR, Warner BW.
    J Pediatr Surg; 2018 Jun; 53(6):1203-1207. PubMed ID: 29636182
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
    Halpern MD, Holubec H, Clark JA, Saunders TA, Williams CS, Dvorak K, Dvorak B.
    Biol Neonate; 2006 Jun; 89(4):227-35. PubMed ID: 16319449
    [Abstract] [Full Text] [Related]

  • 3. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
    Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, Dvorak K, Boitano SA, Dvorak B.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment.
    Khailova L, Dvorak K, Arganbright KM, Williams CS, Halpern MD, Dvorak B.
    Pediatr Res; 2009 Aug; 66(2):140-4. PubMed ID: 19390485
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor and necrotizing enterocolitis.
    Coursodon CF, Dvorak B.
    Curr Opin Pediatr; 2012 Apr; 24(2):160-4. PubMed ID: 22227788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis.
    Maynard AA, Dvorak K, Khailova L, Dobrenen H, Arganbright KM, Halpern MD, Kurundkar AR, Maheshwari A, Dvorak B.
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G614-22. PubMed ID: 20539009
    [Abstract] [Full Text] [Related]

  • 15. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
    Wei J, Besner GE.
    J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
    [Abstract] [Full Text] [Related]

  • 16. Bile acids induce ileal damage during experimental necrotizing enterocolitis.
    Halpern MD, Holubec H, Saunders TA, Dvorak K, Clark JA, Doelle SM, Ballatori N, Dvorak B.
    Gastroenterology; 2006 Feb; 130(2):359-72. PubMed ID: 16472592
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mucosal loss with increased expression of IL-6, IL-8, and COX-2 in a formula-feeding only neonatal rat model of necrotizing enterocolitis.
    Bergholz R, Zschiegner M, Eschenburg G, Wenke K, Tiemann B, Roth B, Appl B, Reinshagen K, Sommerfeldt D, Ridderbusch I.
    J Pediatr Surg; 2013 Nov; 48(11):2301-7. PubMed ID: 24210203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model.
    Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, Amer M, Xiao Y, Thomson R.
    Gastroenterology; 1999 Sep; 117(3):577-83. PubMed ID: 10464133
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.